This course has expired. View available courses.
Diabetes
Incretin Therapy in Type 2 Diabetes: Implementing the CDA Guidelines – MOC Section 1
DURATION
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
EXPIRY DATE
2014-08-06
Learning objectives
At completion of the program, the participant should be able to implement the new 2013 CDA clinical practice guidelines in the following aspects of incretin-based management of type 2 diabetes:
- Initiate and adjust therapy for timely management
- Describe and differentiate the GLP-1 receptor agonist and DPP-4 inhibitor therapies
- Individualize treatment, based on agent and patient characteristics
- Support patient adherence to and satisfaction with therapy
Cost of course:
Free